These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 21475008

  • 1. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system.
    Gertler R, Stein HJ, Langer R, Nettelmann M, Schuster T, Hoefler H, Siewert JR, Feith M.
    Ann Surg; 2011 Apr; 253(4):689-98. PubMed ID: 21475008
    [Abstract] [Full Text] [Related]

  • 2. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM.
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [Abstract] [Full Text] [Related]

  • 3. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT, Chapman C, Shen J, Su Z, Koong AC.
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [Abstract] [Full Text] [Related]

  • 4. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
    Rizk NP, Venkatraman E, Bains MS, Park B, Flores R, Tang L, Ilson DH, Minsky BD, Rusch VW, American Joint Committee on Cancer.
    J Clin Oncol; 2007 Feb 10; 25(5):507-12. PubMed ID: 17290058
    [Abstract] [Full Text] [Related]

  • 5. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma.
    Yamamoto S, Ishihara R, Motoori M, Kawaguchi Y, Uedo N, Takeuchi Y, Higashino K, Yano M, Nakamura S, Iishi H.
    Am J Gastroenterol; 2011 Jun 10; 106(6):1048-54. PubMed ID: 21343920
    [Abstract] [Full Text] [Related]

  • 6. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B, Pernaute AS, Elia S, Buonomo OC, Valladares LD, Aguirre EP, Petrella G, Garcia AT.
    Interact Cardiovasc Thorac Surg; 2010 May 10; 10(5):704-8. PubMed ID: 20154347
    [Abstract] [Full Text] [Related]

  • 7. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S, Mailey B, Artinyan A, Metchikian M, Shibata S, Kernstine K, Kim J.
    Ann Surg Oncol; 2011 Feb 10; 18(2):551-8. PubMed ID: 20839062
    [Abstract] [Full Text] [Related]

  • 8. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
    Barthel JS, Kucera ST, Lin JL, Hoffe SE, Strosberg JR, Ahmed I, Dilling TJ, Stevens CW.
    Gastrointest Endosc; 2010 Feb 10; 71(2):235-40. PubMed ID: 20003971
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH, Odze RD, Mueller JD, Wang H, Redston M, Bertagnolli MM.
    J Thorac Cardiovasc Surg; 2004 Jun 10; 127(6):1579-86. PubMed ID: 15173710
    [Abstract] [Full Text] [Related]

  • 10. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
    Brücher BL, Becker K, Lordick F, Fink U, Sarbia M, Stein H, Busch R, Zimmermann F, Molls M, Höfler H, Siewert JR.
    Cancer; 2006 May 15; 106(10):2119-27. PubMed ID: 16607651
    [Abstract] [Full Text] [Related]

  • 11. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL.
    Ann Thorac Surg; 2016 Mar 15; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [Abstract] [Full Text] [Related]

  • 12. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC, Schlechtweg N, Veltzke-Schlieker W, Thuss-Patience P, Pratschke J, Neuhaus P, Schumacher G.
    Zentralbl Chir; 2009 Sep 15; 134(5):455-61. PubMed ID: 19757346
    [Abstract] [Full Text] [Related]

  • 13. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC, Port JL, Paul S, Stiles BM, Altorki NK.
    Ann Thorac Surg; 2009 Jul 15; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [Abstract] [Full Text] [Related]

  • 14. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
    Chao YK, Yeh CJ, Chang HK, Tseng CK, Chu YY, Hsieh MJ, Wu YC, Liu HP.
    Ann Surg Oncol; 2011 Feb 15; 18(2):529-34. PubMed ID: 20697822
    [Abstract] [Full Text] [Related]

  • 15. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR.
    Cancer; 1999 Nov 01; 86(9):1700-11. PubMed ID: 10547542
    [Abstract] [Full Text] [Related]

  • 16. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
    Vallböhmer D, Hölscher AH, DeMeester S, DeMeester T, Salo J, Peters J, Lerut T, Swisher SG, Schröder W, Bollschweiler E, Hofstetter W.
    Ann Surg; 2010 Nov 01; 252(5):744-9. PubMed ID: 21037429
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun 01; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 18. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK, Chan SC, Liu YH, Chen HW, Wan YL, Chang HK, Fan KH, Liu HP.
    Ann Surg; 2009 Mar 01; 249(3):392-6. PubMed ID: 19247024
    [Abstract] [Full Text] [Related]

  • 19. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
    von Rahden BH, Feith M, Stein HJ.
    Zentralbl Chir; 2006 Apr 01; 131(2):97-104. PubMed ID: 16612774
    [Abstract] [Full Text] [Related]

  • 20. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.
    Yang Q, Cleary KR, Yao JC, Swisher SG, Roth JA, Lynch PM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT.
    Dis Esophagus; 2004 Apr 01; 17(1):38-43. PubMed ID: 15209739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.